AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis	Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder	Recruiting	Phase 1	2026-04-14		NCT06665165

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Amylyx Pharmaceuticals Inc.	3

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Alliance for Multispecialty Research, LLC	Knoxville	United States	5
Georgetown University Hospital Pasquerilla Healthcare Center	Washington D.C.	United States	1
Houston Methodist Neurological Institute	Houston	United States	18
London Health Sciences Centre	London	Canada	1
Massachusetts General Hospital, Healey & AMG Center for ALS	Boston	United States	1
Mayo Clinic in Florida	Jacksonville	United States	89
Mayo Clinic in Rochester	Rochester	United States	687
McGill University Health Centre - Centre for Innovative Medicine	Montreal	Canada	2
McMaster University	Hamilton	Canada	8
Orlando Regional Medical Center, Orlando Health Neuroscience Institute	Orlando	United States	1
Temple University of The Commonwealth System of Higher Education	Philadelphia	United States	4
University of Calgary	Calgary	Canada	31
University of California, San Diego	La Jolla	United States	38
University of Florida	Gainesville	United States	79